Improving adherence to antiretroviral therapy (ART) in youth living with HIV requires interventions that target both family ...

Prademagene zamikeracel (Zevaskyn) is the first and only cell-based gene therapy for wound treatment in patients with ...

K. "Vish" Viswanath, PhD, is a professor of population sciences at Dana-Farber Cancer Institute and a professor of health ...

Evaluating the impact of the Inflation Reduction Act (IRA) will require real-time data and effective therapy metrics, ...

Disparities in prescribing semaglutide and tirzepatide for obesity reveal social factors affecting access and highlight the ...

Early actions by the new administration signal major changes in health policy, taxes, and pharmaceutical pricing.

Following results from their new retrospective study, the researchers suggested that immediate reconstruction of the nose ...

Combining immunotherapy with chemotherapy shows promise in enhancing survival rates for extensive-stage small cell lung ...

With artificial intelligence (AI) capabilities freeing up workers and driving billions in gains, pharmacy may soon see a 75% ...

New treatments for neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME) enhance patient care with gene therapies and new mechanisms of action on the horizon, explained ...

From a meeting that celebrates basic research and being "first," a look at 3 data sets on therapies that would break new ...

Raymond Osarogiagbon, MD, discusses the challenges of implementing lung cancer screening guidelines and the need for increased awareness and access.